Skip to content

Dr. Barry Dworkin

  • About
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology
  • Experimental drug reverses of cognitive impairment in Alzheimer mouse model

    May 17, 2013

    Madely Health Headlines Commentary for May 17, 2013 [display_podcast] Source: Scientists develop drug that may slow Alzheimer’s Reference: The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice

  • Focused-beam-ultrasound trial will investigate efficacy to treat early stage prostate cancer

    April 25, 2013

    Madely Health Headlines Commentary for April 25, 2013 [display_podcast] Source: Clinical trial first for less invasive procedure to treat prostate cancer

  • New cell treatment may help treat MS and Cerebral Palsy

    April 15, 2013

    Madely Health Headlines Commentary for April 15, 2013 [display_podcast] Source: New Technique Holds Promise For The Treatment Of Multiple Sclerosis And Cerebral Palsy Reference: Transcription factor–mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells

  • More research required to study hypothesis of autism-gastrointestinal disease link

    April 8, 2013

    Madely Health Headlines Commentary for April 8, 2013 [display_podcast] Source: Researchers probe link between autism and gastrointestinal problems  

  • Treating high blood pressure may reduce risk of Alzheimers for people with specific genetic marker

    March 22, 2013

    Madely Health Headlines Commentary for March 22, 2013 [display_podcast] Source: BP Control May Help Slow Alzheimer’s Reference: Rodrigue KM, et al “Risk factors for β-amyloid deposition in healthy aging: Vascular and genetic effects” JAMA Neurol 2013; DOI: 10.1001/jamaneurol.2013.1342.

  • MS drug study: Beware drug company press releases that are used to report drug trial results, and of course it has favourable results

    March 21, 2013

    Madely Health Headlines Commentary for March , 2013 [display_podcast] Source: Excellent Results For MS Drug “Plegridy” Reference: The results were presented at the American Academy of Neurology’s 65th Annual Meeting. It is not published. Further it compares the drug to placebo, a useless marker for clinicians. We want to know how it fares against other medication of…

  • New understanding of mechanism of brain disease in athletes coming up for discussion on Sunday House Call

    March 15, 2013

    Madely Health Headlines Commentary for March 15, 2013  

  • Study relating certain hormone levels to sex offender recidivism very preliminary

    March 13, 2013

    Madely Health Headlines Commentary for March 13, 2013 [display_podcast] Source: Ottawa sexual behaviours clinic helps science understand re-offenders  

  • Ottawa Hospital study to examine best means of treating binge eating disorders

    March 12, 2013

    Madely Health Headlines Commentary for March 12, 2013 [display_podcast] Source: Ottawa Hospital tackling eating disorders  

  • Facebook
  • X

Notifications